EllenRx® Prior Authorization Card

Xifaxan (rifaximin)

FDA-approved uses
Travelers' diarrhea, Preventing hepatic encephalopathy (HE) from coming back, IBS-D
How it's given
By mouth
Typical first approval
For HE: 12 months. For IBS-D: 14 days (one course).
Sources checked
2026-11-10

What payers commonly require

  • Diagnosis of HE or IBS-DInsurers check that you have a condition Xifaxan is approved to treat, such as hepatic encephalopathy (HE) or IBS with diarrhea (IBS-D).Source: Aetna, UnitedHealthcare
  • For HE: taken along with lactuloseFor hepatic encephalopathy, insurers usually want Xifaxan added on to lactulose, the standard first treatment, unless you cannot take lactulose.Source: Aetna, UnitedHealthcare
  • For IBS-D repeat courses: symptoms came backFor a new 14-day course, insurers want to see that your IBS-D symptoms returned after an earlier course.Source: Aetna, UnitedHealthcare
  • For IBS-D: fewer than 3 courses so farInsurers usually stop approving after 3 courses for IBS-D, which matches the label (first course plus up to 2 repeats).Source: Aetna, UnitedHealthcare, FDA label

Each plan has its own policy. Check the patient's plan before submitting.

Letter of medical necessity

Address each item above in the letter and attach the chart notes that show it: the diagnosis, prior treatments with dates and results, and any required test results.

Draft a letter with Ellen

Patients: see the Xifaxan patient page.

Sources: FDA label (DailyMed), Aetna (August 20, 2026), UnitedHealthcare (Effective Date 10/1/2026).

Not medical advice. For educational use by clinic staff. Ellen does not diagnose conditions or recommend treatments. Payer policies change often; confirm with the patient's plan.